Taysha Gene Therapies (TSHA) Insider Trading & Ownership → The #1 Crypto for AI (From Weiss Ratings) (Ad) Free TSHA Stock Alerts $3.09 0.00 (0.00%) (As of 05/20/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Taysha Gene Therapies (NASDAQ:TSHA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage2.70%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)$15.73 MNumber OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$351,334.11 Get TSHA Insider Trade Alerts Want to know when executives and insiders are buying or selling Taysha Gene Therapies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address TSHA Insider Buying and Selling by Quarter Ad The Freeport SocietyBill Clinton Backing Biden Replacement???Bill Clinton is back. And he just met in Mexico with the one person I believe could REPLACE Joe Biden by August…Click here now for my urgent election forecast. Taysha Gene Therapies Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/17/2023Paul B ManningMajor ShareholderBuy100,000$1.63$163,000.00 8/24/2023Kamran AlamCFOSell33,000$2.33$76,890.00 8/16/2023John A Stalfort IIIDirectorBuy388,889$0.90$350,000.10 8/16/2023Paul B ManningMajor ShareholderBuy16,466,667$0.90$14,820,000.30 8/16/2023Sean P NolanCEOBuy444,444$0.90$399,999.60 7/12/2023R.A. Session IIMajor ShareholderSell80,528$0.71$57,174.88 6/22/2023R.A. Session IIMajor ShareholderSell10,508$0.70$7,355.60 6/20/2023R.A. Session IIMajor ShareholderSell295,653$0.71$209,913.63 (Data available from 1/1/2013 forward) TSHA Insider Trading Activity - Frequently Asked Questions Who is on Taysha Gene Therapies's Insider Roster? The list of insiders at Taysha Gene Therapies includes John A Stalfort III, Kamran Alam, Paul B Manning, Phillip B Donenberg, R.A. Session II, Sean P Nolan, Sukumar Nagendran, and Suyash Prasad. Learn more on insiders at TSHA. What percentage of Taysha Gene Therapies stock is owned by insiders? 2.70% of Taysha Gene Therapies stock is owned by insiders. Learn more on TSHA's insider holdings. Which Taysha Gene Therapies insiders have been buying company stock? The following insiders have purchased TSHA shares in the last 24 months: John A Stalfort III ($350,000.10), Paul B Manning ($17,983,000.30), Sean P Nolan ($399,999.60), and Sukumar Nagendran ($3,400.00). How much insider buying is happening at Taysha Gene Therapies? Insiders have purchased a total of 18,905,000 TSHA shares in the last 24 months for a total of $18,736,400.00 bought. Which Taysha Gene Therapies insiders have been selling company stock? The following insiders have sold TSHA shares in the last 24 months: Kamran Alam ($139,831.62), R.A. Session II ($274,444.11), and Suyash Prasad ($145,109.18). How much insider selling is happening at Taysha Gene Therapies? Insiders have sold a total of 477,034 Taysha Gene Therapies shares in the last 24 months for a total of $559,384.91 sold. More Insider Trading Tools from MarketBeat Related Companies: FATE Insider Selling EDIT Insider Selling VYGR Insider Selling ALLO Insider Selling ALEC Insider Selling LXEO Insider Selling OCGN Insider Selling CABA Insider Selling TCRX Insider Selling CCCC Insider Selling Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Insider Trading is Good News for These Stocks4 Small-Cap Energy Stocks Insiders are Buying 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock Lately This page (NASDAQ:TSHA) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 Media4 Cryptos BETTER than BitcoinTrue Market InsidersBill Clinton Backing Biden Replacement???The Freeport SocietyThe #1 Crypto for AIWeiss RatingsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarWarren Buffett's "mystery stock"Stansberry ResearchThis Could be Your “Big Money” AI MomentInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Taysha Gene Therapies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.